 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Peptidyl and Non-Peptidyl Oral Glucagon-Like Peptide-1 Receptor Agonists |
| Hun Jee Choe, Young Min Cho |
|
Endocrinol Metab. 2021;36(1):22-29. Published online February 24, 2021 DOI: https://doi.org/10.3803/EnM.2021.102 |
|
Peptidyl and Non-Peptidyl Oral Glucagon-Like Peptide-1 Receptor Agonists Endocrinology and Metabolism. 2021;36(1):22-29  Hepatic glucagon receptor binding and glucose-lowering in vivo by peptidyl and non-peptidyl glucagon receptor antagonists European Journal of Pharmacology. 2004;501(1-3):225-234 Glucagon-like peptide-1 receptor agonists suppress water intake Appetite. 2011;57:S29 Glucagon-like peptide-1 receptor agonists and risk of breast cancer BMJ. 2016;i5519 Risk of acute pancreatitis after glucagon-like peptide-1 receptor agonists Pancreatology. 2019;19:S45-S46 Medicinal Chemistry of Glucagon-Like Peptide Receptor Agonists Progress in Medicinal Chemistry. 2013;45-96 Glucagon-like peptide-1 receptor agonists and cardiovascular disease: from LEADER to EXSCEL Cardiovascular Research. 2018;114(10):e70-e71 Glucagon-like peptide-1 receptor agonists Handbook of Incretin-based Therapies in Type 2 Diabetes. 2016;31-43 Glucagon-like peptide-1 receptor agonists and their effects on weight reduction Journal of Diabetes Investigation. 2012;3(6):490-491 CORRIGENDUM FOR “Glucagon-like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter Inhibitors for Treatment of T2DM” Journal of the Endocrine Society. 2020;4(12): |
